Waldencast Gears Up For Q2 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts

Waldencast plc (WALD) will report Q2 earnings on August 18, with analysts forecasting a $0.05 per share loss despite projected revenue growth to $71.94 million from $63.31 million year-over-year. This earnings release follows the company's July 23 acquisition of Novaestiq Corp. and a recent 6% share price decline to $1.73 on Friday, occurring amidst mixed analyst sentiment that includes a maintained Outperform rating from Telsey Advisory Group and a Buy rating with a reduced price target from Canaccord Genuity.

Analysis

Waldencast plc (WALD) is approaching its Q2 earnings release with a mix of positive and negative indicators. The company is projected to report a quarterly loss of $0.05 per share, signaling ongoing profitability challenges. However, this is contrasted by strong top-line expectations, with projected quarterly revenue of $71.94 million, a significant increase from $63.31 million in the prior-year period. This report will be the first since the July 23 acquisition of Novaestiq Corp, and the market will be looking for commentary on integration and synergies. Investor sentiment appears cautious, as reflected by a recent 6% share price decline to $1.73. Analyst ratings are mixed; while Telsey Advisory Group and Canaccord Genuity maintain Outperform and Buy ratings respectively, Canaccord recently reduced its price target from $6 to $5, and TD Cowen initiated coverage with a more neutral Hold rating. Despite the varied ratings, all listed price targets ($4.00 to $5.00) suggest substantial potential upside from the current trading price, contingent on the company meeting or exceeding its growth targets and demonstrating a clear path to profitability.

Key Decisions for Investors

• Investors should closely monitor the upcoming earnings call for management's guidance on the path to profitability and the financial impact of the recent Novaestiq Corp acquisition.
• The significant disparity between the current stock price of $1.73 and analyst price targets in the $4.00-$5.00 range suggests a high-risk, high-reward scenario, warranting caution ahead of the earnings release.
• Given the recent 6% stock price decline and mixed analyst ratings, it may be prudent to await the Q2 results to validate the company's revenue growth trajectory before adjusting positions.